Calmodulin-Like Skin Protein: A New Marker of Keratinocyte Differentiation  by Méhul, Bruno et al.
Calmodulin-Like Skin Protein: A New Marker of Keratinocyte
Differentiation
Bruno MeÂhul, Dominique Bernard, and Rainer Schmidt
Life Sciences Research, L'OreÂal, Center Charles Zviak, Clichy, France
The expression of the calmodulin-like skin protein, a
recently discovered new skin-speci®c calcium bind-
ing protein, was studied in cultured keratinocytes,
reconstructed human epidermis, and normal human
skin. Using a calmodulin-like skin protein speci®c
polyclonal antibody and Western blot analysis we
could show that in cultured keratinocytes calmodu-
lin-like skin protein expression is strongly induced
after stimulating cell differentiation by increasing the
medium calcium concentration. Known modulators
of epidermal differentiation such as sodium butyrate
and the synthetic retinoid CD 367 strongly affected
calmodulin-like skin protein expression. A more
than 10-fold increase was observed in the presence of
sodium butyrate, whereas CD 367 abolished almost
completely calmodulin-like skin protein expression
already at nanomolar concentrations. Calmodulin,
another calcium binding protein that is expressed
throughout the living layers of the epidermis, is not
affected by these modulators. In normal human skin,
calmodulin-like skin protein expression is restricted
to the stratum granulosum and the lower layers of
the stratum corneum. From these results we con-
clude that calmodulin-like skin protein is a new
marker of late keratinocyte differentiation with a
role distinct from calmodulin. Key words: calcium
binding proteins/differentiation/epidermis/stratum corneum.
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T
he stratum corneum is generated by keratinocytes,
which during their migration from the basal layer
of the epidermis to the surface undergo terminal
differentiation, a process that is known to be
calcium dependent (Hennings et al, 1980). A low
calcium concentration in the basal layer favors keratinocyte
proliferation, whereas increasing calcium in the suprabasal layers
is associated with keratinocyte terminal differentiation (Boyce
and Ham, 1983). The activity of calcium ions is in many cases
mediated by calcium binding proteins, which after complexation
of calcium undergo conformational changes, bind speci®c target
proteins, and modulate their activity (Crivici and Ikura, 1995;
Tabernero et al, 1997).
We have recently discovered and biochemically characterized a
new skin-speci®c calcium binding protein that we named
calmodulin-like skin protein (CLSP) based on its homology
(52%) with calmodulin (CaM) and its tissue-speci®c expression in
the epidermis (MeÂhul et al, 2000). The expression pattern of CLSP
in human epidermis, compared with other markers of keratinocyte
differentiation such as ®laggrin (Steven et al, 1990), suggested
strongly that this new protein might be involved in epidermal
differentiation. Sequencing one of the af®nity puri®ed skin proteins
that binds in the presence of calcium to recombinant CLSP
(rCLSP) revealed 100% identity with transglutaminase-3, a cal-
cium-dependent key enzyme of epidermal differentiation, impli-
cated in the formation of the corni®ed envelope (Reichert et al,
1993; Lee et al, 1996).
These data prompted us to further investigate the differentiation-
related expression of CLSP. Here we describe the expression of
CLSP in cultured keratinocytes, reconstructed epidermis, and
normal human skin, as well as its modulation by two well-known
modulators of keratinocyte differentiation.
MATERIALS AND METHODS
Materials Phenylmethylsulfonyl ¯uoride was purchased from Sigma.
Premade sodium dodecyl sulfate polyacrylamide gels (SDS-PAGE),
Rainbow molecular weight markers, and silver staining kit were from
Amersham Pharmacia Biotech. CaM from human erythrocytes was
obtained from Fluka, and CaM from hog brain was from Roche
Molecular Biochemicals. The rabbit polyclonal antibody against CLSP
was produced by CovalAb, Lyon, France, using rCLSP as antigen and
puri®ed by af®nity chromatography on a column containing immobilized
CLSP (MeÂhul et al, 2000). Mouse anti-CaM (RDI-calmoabm) was
purchased from Research Diagnostics. The synthetic retinoid CD 367
was a kind gift of Galderma R&D, Sophia Antipolis, France.
SDS-PAGE and protein labeling Expression, puri®cation of rCLSP,
and SDS-PAGE were performed as reported previously (MeÂhul et al,
2000). Antibodies and rCLSP were labeled with Alexa Fluor 488 kit
(Molecular Probes). Fluorescent-rCLSP (FrCLSP) was puri®ed using
hydrophobic interaction chromatography as described previously (MeÂhul
et al, 2000).
Cell culture Monolayers of normal human keratinocytes were
generated in medium (KGM from Clonetics) containing low calcium
(0.1 mM) (Watt, 1988). Keratinocyte differentiation was induced by
increasing the calcium concentration to 1.15 mM. To evaluate the effect
of modulators of keratinocyte differentiation on the expression of CLSP,
either the synthetic retinoid CD 367 or sodium butyrate was added at
various concentrations when the cells reached 60% con¯uence,
concomitant with the increase in the calcium concentration to 1.15 mM.
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Cells were treated for 1 wk with a medium change each second day.
Thereafter the medium was removed and the cultures were rinsed with
phosphate-buffered saline (PBS) before storage at ±20°C. Reconstruction
of human epidermis was performed as described before and the samples
were examined after different times of culture ranging from day 1 to day
20 (Tinois et al, 1991).
Immuno¯uorescence microscopy Human skin and reconstructed
epidermis were either dissected, frozen, and stored at ±80°C or cut
directly into 7 mm serial sections for immuno¯uorescence studies. After
rehydration in PBS at room temperature, sections were incubated for
20 min with PBS containing 5% bovine serum albumin (BSA) to saturate
nonspeci®c sites. Sections were washed in PBS, 1% BSA for 10 min and
incubated for 45 min with the respective primary antibody, diluted in
PBS, 0.2% BSA (1:10 for the anti-CLSP immunoaf®nity puri®ed
polyclonal antibody and 1:100 for the anti-CaM monoclonal antibody).
Sections were then rinsed twice with PBS for 5 min and thereafter with
PBS, 1% BSA for 10 min before incubation (45 min) with the respective
¯uorescein isothiocyanate conjugated second antibody (antimouse or
antirabbit) diluted as recommended by the supplier (Sigma) in PBS, 0.2%
BSA. After exhaustive washing in PBS and distilled water, sections were
mounted in Citi¯uor (glycerol/PBS solution) containing 5 mg per ml
propidium iodine to stain the nuclei. Cultured keratinocytes were
washed with PBS and ®xed in methanol for 8 min at 2°C. After
®xation, the cells were rehydrated in PBS and treated as described for
the preparation of sections. Multi¯uorescent detection was analyzed with
a confocal laser scanning microscope LSM 510 (Carl Zeiss, Oberkochen,
Germany).
Figure 1. Western blotting analysis of CLSP expression. CaM, lane
1; rCLSP, lane 2. Extracts from plantar stratum corneum, lane 3; and
total epidermis, lane 4 (SDS-PAGE of CaM stained with Coomassie
blue, lane 1*).
Figure 2. CLSP expression in normal human
epidermis. Immuno¯uorescence labeling of
CLSP in normal human skin using the polyclonal
anti-CLSP antibody (a, b) and CaM with the
monoclonal anti-CaM (c). Nuclei were stained
with propidium iodine (b). Control, without the
®rst antibody (d). E, epidermis; D, dermis; B,
basal layer; SG, stratum granulosum; SC, stratum
corneum. Scale bar: 50 mm.
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Western blot analysis Keratinocytes grown in 24-well culture plates
were homogenized in 1 3 Laemmli buffer containing 2% SDS and
200 mM dithiothreitol (100 ml per well). For each experimental
condition, cells from four wells were pooled and boiled for 10 min
before centrifugation (14,000g for 5 min). For Western blotting analysis,
proteins were transferred to PVDF membrane (Immobilon P, Millipore)
in the presence of 20 mM Tris-HCl, pH 8.3, 192 mM glycine, 0.1%
SDS, and 20% methanol, using a semidry electroblotter (Amersham
Pharmacia Biotech). The ®lters were blocked with 10 mM Tris-HCl,
pH 8.3, 150 mM NaCl, 0.05% Tween 20 (TNT), containing 10%
nonfat milk, at room temperature for 1 h. Thereafter, ®lters were
incubated overnight at 4°C with the primary polyclonal or monoclonal
antibodies, diluted in TNT containing 1% milk. The ®lters were then
washed twice for 10 min in TNT and incubated for 2 h at room
temperature with the respective second antibody coupled to peroxidase
(antirabbit or antimouse IgG, Sigma), diluted in TNT, 1% milk, as
indicated by the suppliers. The bands were visualized using the
SuperSignal CL-HRP Substrate System (Pierce, Rockville, IN) on a
¯uorSmax device (Biorad). Pre-stained molecular weight markers served
as standards and proteins were visualized by Coomassie blue staining.
Other methods Immunoprecipitation of FrCLSP with the anti-CLSP
polyclonal antibody was performed at room temperature. One microliter
of FrCLSP puri®ed by hydrophobic interaction chromatography
(1.35 mg per ml) was diluted in 450 ml of TNT buffer containing 50 ml
of calcium or ethylenediamine tetraacetic acid (EDTA) solution for a
suitable ®nal concentration. After 30 min of slow agitation, 5 ml of anti-
CLSP were added and agitation was continued for 1 h. Protein A-
agarose (40 ml), diluted 1:1 with TNT buffer, was added and after an
additional 30 min agitation the agarose beads were centrifuged at 10,000g
for 3 min. The resulting pellet was washed in 1 ml of TNT buffer
(containing EDTA or calcium) and centrifuged at 10,000g for 3 min.
The beads were then resuspended in 100 ml distilled water and the
¯uorescence was quanti®ed using a ¯uorescence microplate reader (ex/
em: 485/535) (Biolumin from Molecular Dynamics). Preparation of
acetone powder of stratum corneum has been described previously
(LundstroÈm and Egelrud, 1991; MeÂhul et al, 2000). Immunohisto-
chemical detection of CLSP was performed using ABC (Dako) and AEC
(Sigma) kits with biotinylated horseradish peroxydase.
RESULTS AND DISCUSSION
We recently discovered, cloned, and characterized biochemically a
new epidermal calcium binding protein, which, based on its
exclusive and abundant expression in the skin, exhibiting a 52%
homology with CaM, was named calmodulin-like skin protein
(CLSP) (MeÂhul et al, 2000). As epidermal keratinocyte differen-
tiation is closely related to a calcium gradient, increasing from the
basal layer to the granular layer (Hennings et al, 1980), we
speculated early that CLSP might be implicated in the control of
differentiation-speci®c pathways in keratinocytes. Our hypothesis
gained further support when we found that one rCLSP af®nity
puri®ed protein had 100% homology with transglutaminase-3
(MeÂhul et al, 2000), knowing that transglutaminases are key
enzymes of late keratinocyte differentiation, directly involved in the
corni®ed envelope formation (Reichert et al, 1993; Lee et al, 1996).
To identify and localize the CLSP in normal human epidermis,
we developed speci®c antibodies against CLSP, among which we
selected a polyclonal antibody suitable for both Western blotting
and immuno¯uorescence studies. This particular antibody im-
munoprecipitates CLSP only in the presence of calcium. Its ability
to precipitate CLSP is reduced in a concentration-dependent
manner by EDTA (results not shown). From these experiments we
concluded that our antibody recognizes speci®cally the CLSP±
calcium complex, i.e., the opened form of the protein that interacts
with its target proteins. Furthermore, we have evidence that our
antibody does not interfere with the binding of identi®ed ligands to
CLSP (unpublished data).
A qualitative Western blotting analysis performed with the
rCLSP and soluble proteins obtained from normal human epider-
mis and plantar stratum corneum (Fig 1) revealed that the anti-
CLSP decorated rCLSP (Fig 1, lane 2) and a protein with the same
apparent molecular weight (15.9 kDa) in the other extracts (Fig 1
lanes 3, 4). No cross-reactivity was observed with human CaM
(Fig 1, lane 1). The protein with a molecular weight of 6.5 kDa
decorated in the extract of plantar stratum corneum most probably
presents an immunoreactive degradation product of CLSP.
Interestingly, this immunoreactive degradation product is not
detectable in extracts from nonplantar human skin (Fig 1, lane 4),
con®rming earlier observations (MeÂhul et al, 2000) that in normal
human skin CLSP is degraded in the upper stratum corneum into
fragments that have lost their immunoreactivity. The immunor-
eactive 6.5 kDa fragment of the plantar stratum corneum is actually
under investigation to elucidate its possible biologic relevance in
the plantar stratum corneum.
The above-described polyclonal antibody was used to character-
ize CLSP expression in normal human skin. The immuno¯uores-
cence labeling of CLSP in normal human epidermis revealed its
presence ranging from the uppermost layers of the living epidermis
(stratum granulosum) into the lower layers of the stratum corneum
(Fig 2a, b). Its narrow expression pattern becomes particularly
evident in Fig 2b, where the nuclei were stained with propidium
iodine. Epidermal CLSP expression is very close to that described
for ®laggrin (Wollina et al, 1989, 1991), and very distinct from
CaM, which is expressed throughout the living layers of the
epidermis (Fig 2c).
Essentially the same pattern of CLSP expression in normal
human skin is revealed by classical immunohistochemistry
(Fig 3A). Compared to normal human epidermis, the presence
of CLSP in reconstructed human epidermis is characterized by a less
stringent expression pattern with CLSP being present already in
deeper layers of the epidermis and an apparent accumulation at the
cell periphery (Fig 3B). This phenomenon is typical for recon-
structed epidermis and observed for most of the keratinocyte
differentiation markers (Schmidt, 1990).
Figure 3. Immunohistologic detection of
CLSP in normal human and reconstructed
epidermis. Normal human epidermis (A);
reconstructed human epidermis (B). Scale bar:
50 mm.
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The immunohistochemical localization of CLSP in the
epidermis strongly favors the hypothesis of a keratinocyte-
differentiation-related expression. It is well known that
keratinocytes in submerged cultures have a limited ability to
differentiate and that increasing the calcium concentration of the
medium in a con¯uent culture (calcium switch) induces part of
their differentiation program (Hennings et al, 1980). Almost
complete keratinocyte differentiation is obtained by exposing
keratinocytes on an adequate support at the air±liquid interface
(Schmidt, 1990). To obtain more information concerning the
differentiation-related expression of CLSP in keratinocytes, we
performed Western blot analysis of extracts obtained from (i)
keratinocytes cultured either in low (0.1 mM) or high
(1.15 mM) calcium (Fig 4A) and (ii) keratinocytes after air
exposure during the reconstruction of a human epidermis
(Fig 4B). The results clearly show that CLSP is hardly
detectable in proliferating, low calcium keratinocytes, and that
in the presence of calcium its expression is strongly induced.
Direct evidence that CLSP expression correlates directly with
the degree of keratinocyte differentiation is provided in
Fig 4(B). CLSP is absent 1 d after seeding the keratinocytes
and barely detectable at day 3, when the air-exposed culture is
composed of three to four keratinocyte layers only, without
apparent signs of differentiation. It is only at day 6 of the
culture, when the ®rst layers of the stratum corneum are
formed, that CLSP is present at an appreciable level. Its
expression increases until day 10 and disappears almost
Figure 4. Differentiation-related expression of CLSP. (A) Western
blot analysis of CLSP expression in cultured human keratinocytes kept for
several days in the presence of low (0.1 mM) (±) and high (1.15 mM) (+)
calcium. (B) Western blot analysis of CLSP and CaM during the
reconstruction of human epidermis at different time intervals (days 1±20).
Figure 5. Confocal microscopy of CLSP
expression in a culture of con¯uent
keratinocytes. The immuno¯uorescence study
was performed with an anti-CLSP Alexa FluorTM
488 labeled polyclonal antibody in a con¯uent,
high calcium keratinocyte culture. Nuclei were
stained with propidium iodine. (A) Compilation
of serial sections of a typical ``dome formation''
from top to bottom analyzed by confocal
microscopy (high magni®cation); arrow indicates
the ``dome formation''. (B) Transversal view of
(A). Scale bars: 50 mm.
Figure 6. Modulation of CLSP expression in cultured
keratinocytes. (A) CLSP expression in the presence of increasing
concentrations of sodium butyrate. (B) CLSP expression in the presence
of increasing concentrations of CD 367, a synthetic retinoid
(quanti®cation of CLSP expression is based on Western blot analysis).
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completely between days 15 and 20 of the culture. The
disappearance of CLSP at that stage of the culture is no surprise
and is explained by the fact that after day 15, in most of the
reconstructed skin models, keratinocyte proliferation is reduced
to almost zero. Under such conditions, the degradation of
CLSP into nonimmunoreactive products (MeÂhul et al, 2000) is
no longer compensated by newly synthesized CLSP, resulting in
the elimination of the immunoreactive CLSP. It is interesting to
note that CaM appears already in nondifferentiated keratinocytes
and is not degraded as CLSP is at day 20.
The observation that nondifferentiated, proliferating, sub-
merged keratinocytes do not express CLSP (see Western blot
analysis, Fig 4A) was con®rmed in a confocal microscopy
analysis of a con¯uent keratinocyte culture (Fig 5). It is known
that prolonged culture of con¯uent keratinocytes results in the
local formation of a multilayered, three to four layer tissue, also
described as ``dome formation''. Keratinocytes in the uppermost
layer of the dome have an advanced differentiation status
compared to the basal cells. Immuno¯uorescence labeling of
CLSP in such a culture with subsequent confocal microscopy
analysis gave evidence that CLSP expression is restricted to
keratinocytes forming the upper part of the dome, i.e.,
differentiating keratinocytes (Fig 5A, B).
Keratinocyte proliferation and differentiation, and in conse-
quence the expression of speci®c markers, can be modulated.
To investigate whether CLSP expression is under the control of
well-known modulators of differentiation such as retinoids
(Asselineau et al, 1989; Feng et al, 1997) or sodium butyrate
(Schmidt et al, 1989; Saunders et al, 1999), we performed a set
of experiments. Keratinocytes were exposed either to the well-
characterized synthetic retinoid CD 367 (Martin et al, 1992) or
sodium butyrate with subsequent quantitative analysis of CLSP
expression. We selected the synthetic retinoid CD 367 to
inhibit differentiation as this molecule has become a standard in
retinoid research because it is light and chemically stable, not
metabolized, and modulates gene expression via the same
nuclear receptors as retinoic acid. To induce keratinocyte
differentiation we used the histone deacetylase inhibitor sodium
butyrate for its described mode of action in keratinocytes
(Schmidt et al, 1989). It was very interesting to observe that
CD 367 reduced CLSP expression by more than 50% already at
1 nM and almost completely at 10 nM (Fig 6A) whereas
sodium butyrate at 1 mM stimulated CLSP expression almost
10-fold (Fig 6B). This modulation pro®le of CLSP is almost
identical to that described for epidermal transglutaminase or
TG1 (Michel et al, 1989; Schmidt et al, 1989), a keratinocyte
differentiation marker enzyme responsible for the corni®ed
envelope formation. It is interesting to note that the expression
of CaM was not affected by these modulators (results not
shown) indicating again that, despite a 52% homology, CLSP is
very distinct from CaM, one of the best described calcium
binding proteins in the skin. We found that CaM is expressed
throughout the living epidermis and not at all related to
keratinocyte differentiation.
One might argue that the ®nding that CLSP expression in
normal human skin is restricted to the stratum granulosum and
the lower layers of the stratum corneum is an artifact based on
the fact that our polyclonal antibody recognizes only the CLSP±
calcium complex, and is unable to detect free CLSP in lower,
undifferentiated levels of the epidermis. Indirect evidence that
this is not the case is provided by earlier reverse transcriptase
polymerase chain reaction studies that revealed that mRNA
coding for CLSP could only be detected in keratinocytes in an
advanced state of differentiation (MeÂhul et al, 2000).
We speculate that the late expression of CLSP during
keratinocyte differentiation in the stratum granulosum indicates
an implication in the control of major events at this important
transition from the living to the anucleated epidermis. Its high
binding af®nity for transglutaminase-3 (MeÂhul et al, 2000), a
calcium-dependent enzyme implicated in the corni®ed envelope
formation, further strengthens this hypothesis. Experiments are
actually in progress to elucidate the exact role of CLSP in the
skin.
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